Clinical trial investigators and site coordinators
Preparing for an FDA inspection of a clinical trial site
使用场景
关于
The Clinical Trials mind map template from Xmind is a comprehensive reference for clinical research professionals, covering 187 nodes across 16 major branches including Laws, study protocol, IRB, informed consent, and FDA regulations. It details key documents like Form FDA 1572, the Investigator's Brochure, and NDA new drug application, and highlights critical events such as the Jesse Gelsinger 1999 case. This template serves as a structured cheat sheet for understanding GCP, FDA oversight, and post-drug approval responsibilities, making it an essential study aid for clinical trial coordinators, investigators, and regulatory affairs specialists. The mind map organizes complex regulatory frameworks into digestible sections, with nodes like 'Common GCP violations' listing failure to follow study protocol and informed consent violations, while 'FDA's Animal Efficacy Rule' explains how animal studies can support drug approval when human trials are not feasible.
使用条款何时使用此模板
Clinical research associates and training managers
Training new staff on Good Clinical Practice (GCP) and regulatory compliance
Clinical trial sponsors and protocol writers
Developing a new study protocol and ensuring all regulatory requirements are met
如何使用此模板
步骤 1
Launch and Explore Core Branches
Open the template in Xmind to navigate through the sixteen major branches covering laws, protocols, and FDA regulations.
步骤 2
Review Details and Customize Nodes
Expand collapsed sub-topics to study specific GCP violations or forms and add your own research notes to personalize the content.
步骤 3
Export for Training and Reference
Save your finalized mind map as a PDF or image to use as a structured cheat sheet for clinical research presentations.
常见问题
The template covers 187 nodes across key topics: Laws (21 CFR, ICH GCP), study protocol, roles of sponsor, IRB, monitor, investigator, informed consent, Investigator's Brochure, Form FDA 1572, 2009 Guidance, FDA Form 483, common GCP violations, Jesse Gelsinger case, Animal Efficacy Rule, NDA, and post-drug approval responsibilities.
Use the 'Common GCP violations' branch to review frequent issues like protocol deviations and informed consent errors. The 'FDA form 483' section explains inspection outcomes (NAI, VAI, OAI). Customize the template by adding your own audit checklist nodes.
Yes, it provides a structured overview of regulatory documents (Form FDA 1572, Investigator's Brochure) and roles (sponsor, monitor, investigator). Trainers can use it as a visual aid to explain the clinical trial lifecycle and compliance requirements.
Yes, the 'Post Drug Approval Respns' branch (abbreviated in the tree) includes FDA oversight after marketing. The template also references NDA goals and Drug Marketing Approval Applications.
Absolutely. Open the .xmind file in Xmind, then modify the 'study protocol' branch to include your study's objectives, design, dosages, and statistical plan. Add new subtopics as needed.
有好的模板想分享？
把你的思维导图模板分享给全球创作者，从你的作品中获得收益。
免费模板